CAS number: 26780-50-7

CDE registration number: F20190001476（A）

Pharmacopoeia specification compliance: ChP/USP

Storage: In an airtight container, in a freezer or a refrigerator (-20 ~ 8 ℃), maintain the product’s temperature close to the room temperature before the seal is removed to decrease the degradation caused by the condensation water.

Properties and Benefits

l Degradable organic compound with high molecular weight, with good biocompatibility, film-forming and vesicle-forming properties.

l Advanced polymerization and refining technologies can guarantee excellent batch-to-batch repeatability.

l Low impurities and monomer residues, low residual catalyst content, can be used for sensitive API to ensure the stability of the preparations.

l Bacterial endotoxins and micro-organisms are strictly controlled, meet the requirements of parenteral and inhalation dosage forms.

l Products can be customized according to customers’ needs and preferences.

Applications

l As a degradable carrier material, PLGA can be employed for sustained and controlled release dosage forms, such as microspheres, nanocapsules, gels, etc.

返回列表